Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein ...

Molecular recurrence signals preceded symptoms or imaging in all recurrences observed, indicating ctDNA may enable earlier ...

Company shares spiked more than 60% after the therapy surpassed Wall Street benchmarks in Phase 1 testing against late-line ...

In 2025, CytomX remained focused on controlling costs and efficiently progressing its pipeline programs. Total operating expense for 2025 was $98.6 million compared to $113.1 million for 2024, a ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Colorectal cancer, or cancer of the bowel or rectum, has long been associated with older adults. However, in recent years, ...

Starting in October 2025, the expansion doses of 8.6 mg/kg and 10 mg/kg were prioritized for dose optimization utilizing ...

Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a ...

Bladder cancer is often discovered because a person notices blood in their urine. For many patients, this is the first warning sign that something is wrong. Seeing this change usually encourages ...

Apollo Hospitals Chennai has launched the Apollo Institute of Robotics & Telesurgery (ART), a new initiative aimed at ...

Jane Locke’s ordeal began in November 2021 following a severe allergic reaction to the chemotherapy medication that left her ...

Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...